In the US, Iodixanol (iodixanol systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Aortography, Cerebral Arteriography, Computed Tomography, Coronary Arteriography, Intra-arterial Digital Subtraction Angiography, Peripheral Arteriography, Renal Arteriography, Urography and Venography.
US matches:
- Iodixanol
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V08AB09
CAS registry number (Chemical Abstracts Service)
0092339-11-2
Chemical Formula
C35-H44-I6-N6-O15
Molecular Weight
1550
Therapeutic Category
Contrast medium
Chemical Name
1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
Foreign Names
- Iodixanolum (Latin)
- Iodixanol (German)
- Iodixanol (French)
- Iodixanol (Spanish)
Generic Names
- Iodixanol (OS: USAN, BAN)
- 2-5410-3A (IS: Nycomed)
- Iodixanol (PH: USP 32)
Brand Names
- Visipaque
Amersham, Czech Republic; Amersham, Spain; Amersham, Greece; Amersham, Hungary; Amersham, Iceland; Amersham, Norway; Amersham, New Zealand; Amersham, Romania; Amersham, Serbia; Daiichi Sankyo, Japan; GE Healthcare, Austria; GE Healthcare, Australia; GE Healthcare, Belgium; GE Healthcare, Switzerland; GE Healthcare, Germany; GE Healthcare, Estonia; GE Healthcare, Finland; GE Healthcare, France; GE Healthcare, Croatia (Hrvatska); GE Healthcare, Italy; GE Healthcare, Lithuania; GE Healthcare, Luxembourg; GE Healthcare, Latvia; GE Healthcare, Malta; GE Healthcare, Poland; GE Healthcare, Sweden; GE Healthcare, United States; Higiea, Slovenia; Nycomed, Israel; Nycomed, Oman; Opakim, Turkey; Sanofi-Aventis, Brazil; GE Healthcare ASNO, Denmark
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment